2024年最新SCI影响因子

江湖一盏灯

2024年6月20日，英国伦敦——科睿唯安今天发布2024年度《期刊引证报告》（JCR™）。报告覆盖全面的高质量期刊资源，并按学科进行排名，便于学术机构、研究人员和出版机构评估期刊在全球科研领域的重要性。今年参与排名的期刊有所变化，新增了 Emerging Sources Citation Index 收录的期刊。

《期刊引证报告》只收录符合 Web of Science 核心合集严格质量标准的期刊，确保用户可以放心地依赖所提供的信息和描述性数据。每年发布一次的《期刊引证报告》提供了丰富的独立于出版机构的数据、指标和分析，包括广为认可的期刊影响因子 (JIF™) 和期刊引文指标（JCI），以加深用户对期刊学术影响力的了解。

今年的期刊引证报告首次纳入了各学科类别的统一排名。被编入 Web of Science 核心合集多个索引的九个学科类别将不再有单独的 JIF 排名。现在每个索引单独的 JIF 排名将被取消，这些期刊将在学科类别中获得单一排名。例如，SCIE 和 SSCI 同时收录的精神病学学科的期刊现在将在该学科排名中进行统一排名，而不会有两个排名。

         影响因子前50名（附件为全部名单）

Name	Abbr Name	ISSN	EISSN	JIF	JIF5Years	Category
CA-A CANCER JOURNAL FOR  CLINICIANS	CA-CANCER J CLIN	0007-9235	1542-4863	503.1	297.0	ONCOLOGY|Q1|1/322
NATURE REVIEWS DRUG DISCOVERY	NAT REV DRUG DISCOV	1474-1776	1474-1784	122.7	114.9	PHARMACOLOGY & PHARMACY|Q1|1/354
LANCET	LANCET	0140-6736	1474-547X	98.4	106.9	MEDICINE, GENERAL & INTERNAL|Q1|1/325
NEW ENGLAND JOURNAL OF  MEDICINE	NEW ENGL J MED	0028-4793	1533-4406	96.2	94.3	MEDICINE, GENERAL & INTERNAL|Q1|2/325
BMJ-British Medical Journal	BMJ-BRIT MED J	0959-535X	1756-1833	93.6	69.9	MEDICINE, GENERAL & INTERNAL|Q1|3/325
NATURE REVIEWS MOLECULAR CELL  BIOLOGY	NAT REV MOL CELL BIO	1471-0072	1471-0080	81.3	115.5	CELL BIOLOGY|Q1|1/205
Nature Reviews Clinical  Oncology	NAT REV CLIN ONCOL	1759-4774	1759-4782	81.1	81.5	ONCOLOGY|Q1|2/322
Nature Reviews Materials	NAT REV MATER	2058-8437	2058-8437	79.8	85.7	NANOSCIENCE & NANOTECHNOLOGY|Q1|1/140
Nature Reviews Disease Primers	NAT REV DIS PRIMERS	2056-676X	2056-676X	76.9	92.6	MEDICINE, GENERAL & INTERNAL|Q1|4/325
NATURE REVIEWS CANCER	NAT REV CANCER	1474-175X	1474-1768	72.5	77.2	ONCOLOGY|Q1|3/322
NATURE REVIEWS MICROBIOLOGY	NAT REV MICROBIOL	1740-1526	1740-1534	69.2	81.3	MICROBIOLOGY|Q1|1/161
NATURE REVIEWS IMMUNOLOGY	NAT REV IMMUNOL	1474-1733	1474-1741	67.7	78.1	IMMUNOLOGY|Q1|1/181
Foundations and Trends in  Machine Learning	FOUND TRENDS MACH LE	1935-8237	1935-8245	65.3	70.8	COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE|Q1|1/197
JAMA-JOURNAL OF THE AMERICAN  MEDICAL ASSOCIATION	JAMA-J AM MED ASSOC	0098-7484	1538-3598	63.1	66.8	MEDICINE, GENERAL & INTERNAL|Q1|5/325
World Psychiatry	WORLD PSYCHIATRY	1723-8617	2051-5545	60.5	55.5	PSYCHIATRY|Q1|1/276
NATURE MEDICINE	NAT MED	1078-8956	1546-170X	58.7	59.2	MEDICINE, RESEARCH & EXPERIMENTAL|Q1|1/189
ANNALS OF ONCOLOGY	ANN ONCOL	0923-7534	1569-8041	56.7	38.2	ONCOLOGY|Q1|4/322
CHEMICAL REVIEWS	CHEM REV	0009-2665	1520-6890	51.4	63.5	CHEMISTRY, MULTIDISCIPLINARY|Q1|1/230
NATURE	NATURE	0028-0836	1476-4687	50.5	54.4	MULTIDISCIPLINARY SCIENCES|Q1|1/134
Nature Reviews Methods Primers	NAT REV METHOD PRIME	N/A	2662-8449	50.1	50.1	MULTIDISCIPLINARY SCIENCES|Q1|2/134
Nature Energy	NAT ENERGY	2058-7546	2058-7546	49.7	62.3	MATERIALS SCIENCE, MULTIDISCIPLINARY|Q1|2/438
Nature Reviews Earth &  Environment	NAT REV EARTH ENV	N/A	2662-138X	49.7	54.5	GEOSCIENCES, MULTIDISCIPLINARY|Q1|1/253
CANCER CELL	CANCER CELL	1535-6108	1878-3686	48.8	42.1	ONCOLOGY|Q1|5/322
LANCET NEUROLOGY	LANCET NEUROL	1474-4422	1474-4465	46.5	51.6	CLINICAL NEUROLOGY|Q1|1/277
Nature Reviews  Gastroenterology & Hepatology	NAT REV GASTRO HEPAT	1759-5045	1759-5053	45.9	65.1	GASTROENTEROLOGY & HEPATOLOGY|Q1|1/143
REVIEWS OF MODERN PHYSICS	REV MOD PHYS	0034-6861	1539-0756	45.9	52.1	PHYSICS, MULTIDISCIPLINARY|Q1|1/110
CELL	CELL	0092-8674	1097-4172	45.5	49.0	CELL BIOLOGY|Q1|4/205
Nature Reviews Physics	NAT REV PHYS	N/A	2522-5820	44.8	44.6	PHYSICS, MULTIDISCIPLINARY|Q1|2/110
SCIENCE	SCIENCE	0036-8075	1095-9203	44.7	50.3	MULTIDISCIPLINARY SCIENCES|Q1|3/134
Lancet Diabetes &  Endocrinology	LANCET DIABETES ENDO	2213-8587	2213-8595	44.0	38.2	ENDOCRINOLOGY & METABOLISM|Q1|1/186
eScience	ESCIENCE	N/A	2667-1417	42.9	42.9	MATERIALS SCIENCE, MULTIDISCIPLINARY|Q1|3/438
Nature Catalysis	NAT CATAL	2520-1158	2520-1158	42.8	47.0	CHEMISTRY, PHYSICAL|Q1|1/178
JOURNAL OF CLINICAL ONCOLOGY	J CLIN ONCOL	0732-183X	1527-7755	42.1	37.4	ONCOLOGY|Q1|6/322
Nature Reviews Cardiology	NAT REV CARDIOL	1759-5002	1759-5010	41.7	46.5	CARDIAC & CARDIOVASCULAR SYSTEMS|Q1|1/220
LANCET ONCOLOGY	LANCET ONCOL	1470-2045	1474-5488	41.6	42.2	ONCOLOGY|Q1|7/322
Signal Transduction and  Targeted Therapy	SIGNAL TRANSDUCT TAR	2095-9907	2059-3635	40.8	40.5	CELL BIOLOGY|Q1|5/205
CHEMICAL SOCIETY REVIEWS	CHEM SOC REV	0306-0012	1460-4744	40.4	48.1	CHEMISTRY, MULTIDISCIPLINARY|Q1|2/230
NATURE REVIEWS GENETICS	NAT REV GENET	1471-0056	1471-0064	39.1	52.3	GENETICS & HEREDITY|Q1|1/191
Lancet Respiratory Medicine	LANCET RESP MED	2213-2600	N/A	38.7	41.3	RESPIRATORY SYSTEM|Q1|1/100
Joule	JOULE	2542-4351	2542-4351	38.6	44.8	MATERIALS SCIENCE, MULTIDISCIPLINARY|Q1|4/438
Nature Nanotechnology	NAT NANOTECHNOL	1748-3387	1748-3395	38.1	39.6	NANOSCIENCE & NANOTECHNOLOGY|Q1|2/140
Nature Reviews Chemistry	NAT REV CHEM	N/A	2397-3358	38.1	39.6	CHEMISTRY, MULTIDISCIPLINARY|Q1|3/230
EUROPEAN HEART JOURNAL	EUR HEART J	0195-668X	1522-9645	37.6	32.6	CARDIAC & CARDIOVASCULAR SYSTEMS|Q1|2/220
MMWR Surveillance Summaries	MMWR SURVEILL SUMM	1545-8636	1545-8636	37.3	30.2	PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH|Q1|1/403
NATURE MATERIALS	NAT MATER	1476-1122	1476-4660	37.2	44.0	PHYSICS, CONDENSED MATTER|Q1|1/79
LANCET INFECTIOUS DISEASES	LANCET INFECT DIS	1473-3099	1474-4457	36.4	32.4	INFECTIOUS DISEASES|Q1|1/132
NATURE METHODS	NAT METHODS	1548-7091	1548-7105	36.1	45.6	BIOCHEMICAL RESEARCH METHODS|Q1|1/85
CIRCULATION	CIRCULATION	0009-7322	1524-4539	35.5	32.7	PERIPHERAL VASCULAR DISEASE|Q1|1/96